Dopamine transporter SPECT in patients with Parkinson's disease

Kakuigaku

Volumn 37, Issue 2, 2000, Pages 128-129

  Hamano, Tadanori ^a   Tsuchida, Tatsuro ^a   Hirayama, Mikio ^a   Fujiyama, Jiro ^a   Mutoh, Tatsuro ^a   Yonekura, Yoshiharu ^a   Kuriyama, Masaru ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

123I J CIT; Dopamine transporter; Parkinson's disease; SPECT; Webster rating scale

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE; DOPAMINE TRANSPORTER; IODINE 123;

ADULT; AGED; ARTICLE; BODY POSTURE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DYSTONIA; FACIES; FEMALE; GAIT; HUMAN; MALE; NEUROTRANSMISSION; PARKINSON DISEASE; PUTAMEN; SELF CARE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPEECH; SUBSTANTIA NIGRA; SYMPTOMATOLOGY;

ADULT; AGED; BRAIN; CARRIER PROTEINS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034012227     PISSN: 00227854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, et al: Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol 1997; 41: 530-539.
2. 123I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 1994; 14: 982-994.
3. van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Wallace E, Zoghbi SS, et al: Age-related decline in striatal dopamine transporter binding with iodine-123-β-CIT SPECT. J Nucl Med 1995; 36: 1175-1181.
4. Asenbaum S, Brucke T, Pirker W, Podreka I, Angelberger P, Wenger S, et al: Imaging of dopamine transporters with iodine-123-β-CIT and SPECT in Parkinson's disease. J Nucl Med 1997; 38: 1-6.
5. 123I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 1995; 38: 589-598.
6. 123I]β-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 1996;46:231-237.
7. 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol 1990; 28: 547-555.
8. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol 1993; 34: 423-431.
9. 123I]β-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl 1997; 50: 9-24.